Mead Johnson Nutrition Company (MJN) : The total money flow in Mead Johnson Nutrition Company (MJN) was negative ($16.46 million), showing the domination of sellers in the Monday trading session. The traders utilized every rise to sell their positions, as seen in the value of trading on downtick to the tune of $27.71 million. Transactions on upticks were comparatively lower at $11.25 million. The uptick to downtick ratio was 0.41. The total block trades on downticks were valued at $16.1 million. The money flow during block trades was negative ($16.1 million) when the stock traded with a gain of $35 cent. Mead Johnson Nutrition Company (MJN) was $89.3, an increase of 0.39% over the previous days close.
Shares of Mead Johnson Nutrition Company appreciated by 1.6% during the last five trading days but lost 2.28% on a 4-week basis. Mead Johnson Nutrition Company is up 5.76% in the last 3-month period. Year-to-Date the stock performance stands at 14.29%.
Mead Johnson Nutrition Company (NYSE:MJN): During Mondays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $88.77 and $88.60 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $89.87. The buying momentum continued till the end and the stock did not give up its gains. It closed at $89.30, notching a gain of 0.39% for the day. The total traded volume was 866,041 . The stock had closed at $88.95 on the previous day.
In a related news, Monteagudo Graciela, officer (SVP&PresAmericas&Glob.Marketg) of Mead Johnson Nutrition Co, unloaded 45,873 shares at an average price of $87.69 on August 4, 2016. The total amount of the transaction was worth $4,022,603, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, childrens nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, childrens milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Companys Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.